Banque Cantonale Vaudoise Vertex Pharmaceuticals Inc Transaction History

Banque Cantonale Vaudoise

$2.43 Billion
Q3 2024

A detailed history of Banque Cantonale Vaudoise transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 11,182 shares of VRTX stock, worth $5.19 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

11,182

Previous 2,462 354.18%

Holding current value

$5.19 Million

Previous $1.15 Million 350.69%

% of portfolio

0.21%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$460.0 - $505.78 $4.01 Million - $4.41 Million	8,720 Added 354.18%	11,182 $5.2 Million
Q2 2024 Jul 31, 2024	BUY	$392.81 - $485.53 $493,369 - $609,825	1,256 Added 104.15%	2,462 $1.15 Million
Q1 2024 Apr 10, 2024	SELL	$407.69 - $446.08 $1.82 Million - $1.99 Million	-4,457 Reduced 78.7%	1,206 $504,000
Q4 2023 Feb 07, 2024	SELL	$343.0 - $410.68 $480,886 - $575,773	-1,402 Reduced 19.84%	5,663 $2.3 Million
Q3 2023 Nov 08, 2023	BUY	$338.18 - $362.46 $291,172 - $312,078	861 Added 13.88%	7,065 $2.46 Million
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $174,503 - $195,310	-555 Reduced 8.21%	6,204 $2.18 Million
Q1 2023 Apr 20, 2023	BUY	$283.23 - $323.1 $453,168 - $516,960	1,600 Added 31.01%	6,759 $2.13 Million
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $805,557 - $906,252	-2,819 Reduced 35.33%	5,159 $1.49 Million
Q3 2022 Oct 17, 2022	SELL	$273.83 - $305.53 $130,890 - $146,043	-478 Reduced 5.65%	7,978 $2.31 Million
Q2 2022 Aug 02, 2022	BUY	$234.96 - $292.55 $75,187 - $93,616	320 Added 3.93%	8,456 $2.38 Million
Q1 2022 May 09, 2022	BUY	$221.42 - $260.97 $432,876 - $510,196	1,955 Added 31.63%	8,136 $2.12 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $1.43 Million - $1.81 Million	-8,088 Reduced 56.68%	6,181 $1.36 Million
Q3 2021 Oct 29, 2021	SELL	$181.39 - $202.99 $551,788 - $617,495	-3,042 Reduced 17.57%	14,269 $2.59 Million
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $924,325 - $1.09 Million	4,930 Added 39.82%	17,311 $3.49 Million
Q1 2021 May 11, 2021	SELL	$207.02 - $241.31 $49,477 - $57,673	-239 Reduced 1.89%	12,381 $2.66 Million
Q4 2020 Feb 05, 2021	BUY	$207.01 - $276.09 $61,274 - $81,722	296 Added 2.4%	12,620 $2.98 Million
Q3 2020 Oct 30, 2020	SELL	$255.65 - $303.1 $1.84 Million - $2.18 Million	-7,197 Reduced 36.87%	12,324 $3.35 Million
Q2 2020 Jul 22, 2020	BUY	$225.48 - $295.8 $2.18 Million - $2.86 Million	9,673 Added 98.22%	19,521 $5.67 Million
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $11,986 - $14,868	-60 Reduced 0.61%	9,848 $2.34 Million
Q4 2019 Feb 10, 2020	BUY	$166.71 - $223.91 $1.65 Million - $2.22 Million	9,908 New	9,908 $2.17 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Account

Banque Cantonale Vaudoise Vertex Pharmaceuticals Inc Transaction History